Susanne Alban

Summary

Affiliation: University of Kiel
Country: Germany

Publications

  1. ncbi Combination of a two-step fluorescence assay and a two-step anti-Factor Xa assay for detection of heparin falsifications and protein in heparins
    Susanne Alban
    Pharmaceutical Institute, Christian Albrechts University, Gutenbergstrasse 76, 24118, Kiel, Germany
    Anal Bioanal Chem 399:681-90. 2011
  2. ncbi Pharmacological strategies for inhibition of thrombin activity
    S Alban
    Pharmaceutical Institute, Christian Albrechts University of Kiel, Kiel, Germany
    Curr Pharm Des 14:1152-75. 2008
  3. ncbi [Pharmacology of heparins and direct anticoagulants]
    S Alban
    Pharmazeutisches Institut, Christian Albrechts Universitat, Kiel
    Hamostaseologie 28:400-20. 2008
  4. ncbi [Natural and synthetic glycosaminoglycans. Molecular characteristics as the basis of distinct drug profiles]
    S Alban
    Pharmazeutisches Institut, Christian Albrechts Universitat zu Kiel, Gutenbergstr 76, 24118 Kiel
    Hamostaseologie 28:51-61. 2008
  5. ncbi [Chromogenic assay for functional determination of TFP]
    S Alban
    Abteilung Pharmazeutische Biologie, Pharmazeutisches Institut, Christian Albrechts Universitat zu Kiel, Gutenbergstr 76, 24118 Kiel
    Hamostaseologie 25:286-92. 2005
  6. ncbi The 'precautionary principle' as a guide for future drug development
    S Alban
    Christian Albrechts University of Kiel, Germany
    Eur J Clin Invest 35:33-44. 2005
  7. ncbi From heparins to factor Xa inhibitors and beyond
    S Alban
    Christian Albrechts University of Kiel, Germany
    Eur J Clin Invest 35:12-20. 2005
  8. ncbi [Paradigm change in anticoagulation. Natural substances that are selective factor Xa inhibitors]
    Susanne Alban
    Pharmazeutisches Institut, , Gutenbergstr. 76 24118 Kiel
    Pharm Unserer Zeit 33:190-4. 2004
  9. ncbi Pharmacological profiles of animal- and nonanimal-derived sulfated polysaccharides--comparison of unfractionated heparin, the semisynthetic glucan sulfate PS3, and the sulfated polysaccharide fraction isolated from Delesseria sanguinea
    Inken Groth
    Pharmaceutical Institute, University of Kiel, 24116 Kiel, Germany
    Glycobiology 19:408-17. 2009
  10. ncbi Comparison of established and novel purity tests for the quality control of heparin by means of a set of 177 heparin samples
    Susanne Alban
    Pharmaceutical Institute, Christian Albrechts University, Gutenbergstr 76, 24118, Kiel, Germany
    Anal Bioanal Chem 399:605-20. 2011

Detail Information

Publications30

  1. ncbi Combination of a two-step fluorescence assay and a two-step anti-Factor Xa assay for detection of heparin falsifications and protein in heparins
    Susanne Alban
    Pharmaceutical Institute, Christian Albrechts University, Gutenbergstrasse 76, 24118, Kiel, Germany
    Anal Bioanal Chem 399:681-90. 2011
    ..Comprehensive information about heparin quality can be obtained by their combined use and the parallel measurement of non-incubated heparin samples...
  2. ncbi Pharmacological strategies for inhibition of thrombin activity
    S Alban
    Pharmaceutical Institute, Christian Albrechts University of Kiel, Kiel, Germany
    Curr Pharm Des 14:1152-75. 2008
    ..This review describes the pharmacological profile of all these anticoagulants...
  3. ncbi [Pharmacology of heparins and direct anticoagulants]
    S Alban
    Pharmazeutisches Institut, Christian Albrechts Universitat, Kiel
    Hamostaseologie 28:400-20. 2008
    ..In September 2008 rivaroxaban has been approved as the first oral DXI. This review describes the development of the anticoagualants as well as the pharmacological profile of the clinically used anticoagualants...
  4. ncbi [Natural and synthetic glycosaminoglycans. Molecular characteristics as the basis of distinct drug profiles]
    S Alban
    Pharmazeutisches Institut, Christian Albrechts Universitat zu Kiel, Gutenbergstr 76, 24118 Kiel
    Hamostaseologie 28:51-61. 2008
    ..This concerns their pharmacodynamics, pharmacokinetics as well as practice-related aspects such as dosage, monitoring, accumulation tendency, antagonisation and HIT-Typ II...
  5. ncbi [Chromogenic assay for functional determination of TFP]
    S Alban
    Abteilung Pharmazeutische Biologie, Pharmazeutisches Institut, Christian Albrechts Universitat zu Kiel, Gutenbergstr 76, 24118 Kiel
    Hamostaseologie 25:286-92. 2005
    ....
  6. ncbi The 'precautionary principle' as a guide for future drug development
    S Alban
    Christian Albrechts University of Kiel, Germany
    Eur J Clin Invest 35:33-44. 2005
    ..In principle, it is thus possible that the prophylaxis and therapy of thromboembolic diseases will become completely independent of animal-derived drugs, which would be in line with the precautionary principle...
  7. ncbi From heparins to factor Xa inhibitors and beyond
    S Alban
    Christian Albrechts University of Kiel, Germany
    Eur J Clin Invest 35:12-20. 2005
    ..In addition to the evaluation of fondaparinux for further indications, chemical modifications of this pentasaccharide such as the long-acting idraparinux are currently under investigation...
  8. ncbi [Paradigm change in anticoagulation. Natural substances that are selective factor Xa inhibitors]
    Susanne Alban
    Pharmazeutisches Institut, , Gutenbergstr. 76 24118 Kiel
    Pharm Unserer Zeit 33:190-4. 2004
  9. ncbi Pharmacological profiles of animal- and nonanimal-derived sulfated polysaccharides--comparison of unfractionated heparin, the semisynthetic glucan sulfate PS3, and the sulfated polysaccharide fraction isolated from Delesseria sanguinea
    Inken Groth
    Pharmaceutical Institute, University of Kiel, 24116 Kiel, Germany
    Glycobiology 19:408-17. 2009
    ..s.-SP might have perspectives for cosmetic applications...
  10. ncbi Comparison of established and novel purity tests for the quality control of heparin by means of a set of 177 heparin samples
    Susanne Alban
    Pharmaceutical Institute, Christian Albrechts University, Gutenbergstr 76, 24118, Kiel, Germany
    Anal Bioanal Chem 399:605-20. 2011
    ..The two two-step-assays represent options to supplement NMR, especially as tests for the initial screening, since they detect any heparin mimetic without requiring special expertise for interpretation of the results...
  11. ncbi Simple fluorescence assay for quantification of OSCS in heparin
    Susanne Lühn
    Pharmaceutical Institute, Christian Albrechts University, Gutenbergstrasse 76, 24118, Kiel, Germany
    Anal Bioanal Chem 399:673-80. 2011
    ..It could be applied not only in the quality control of heparin, but also in clinical practice, to check the applied heparin preparation when a patient suffers any adverse effect...
  12. ncbi Development and evaluation of a fluorescence microplate assay for quantification of heparins and other sulfated carbohydrates
    Susanne Lühn
    Pharmaceutical Institute, Christian Albrechts University, Kiel, Germany
    J Pharm Biomed Anal 52:1-8. 2010
    ..2 and a M(r)>3000 can be quantified as well. By own calibration curves also other sulfated carbohydrates like fondaparinux or other glycosaminoglycans (DS>0.4) can be determined...
  13. ncbi Evaluation of seasonal variations of the structure and anti-inflammatory activity of sulfated polysaccharides extracted from the red alga Delesseria sanguinea (Hudson) Lamouroux (Ceramiales, Delesseriaceae)
    Niels Grünewald
    Pharmaceutical Institute, University of Kiel, Gutenbergstrasse 76, D 24118 Kiel, Germany
    Biomacromolecules 10:1155-62. 2009
    ..48% +/- 1.00%, September, 22.8% +/- 1.2%) due to certain coextraction of starch-like glucans. In principle, algae material can be harvested throughout the year, but the optimum harvesting time is in spring...
  14. ncbi Complement modulating and anticoagulant effects of a sulfated exopolysaccharide released by the cyanobacterium Synechocystis aquatilis
    Rainer B Volk
    Pharmaceutical Institute, University of Kiel, Kiel, Germany
    Planta Med 72:1424-7. 2006
    ..The results indicate that this biotechnologically producible, released polysaccharide represents a specifically acting complement modulator...
  15. ncbi Elastase inhibition assay with peptide substrates - an example for the limited comparability of in vitro results
    Inken Groth
    Pharmaceutical Institute, University of Kiel, Kiel, Germany
    Planta Med 74:852-8. 2008
    ..In conclusion, by the choice of the enzyme substrate, both the apparent maximum activity and the IC (50) of an inhibitor can be influenced. Therefore, only results from identical test systems should be compared....
  16. ncbi Optimized and standardized isolation and structural characterization of anti-inflammatory sulfated polysaccharides from the red alga Delesseria sanguinea (Hudson) Lamouroux (Ceramiales, Delesseriaceae)
    Niels Grünewald
    Department of Pharmaceutical Biology, Pharmaceutical Institute, Christian Albrechts University of Kiel, Kiel, Germany
    Biomacromolecules 10:2998-3008. 2009
    ..8 vs 28.6%). In conclusion, SPs from Delesseria sanguinea can be isolated in reproducibly high quality by using a specific extraction procedure. Thus, an important prerequisite for a potential economical utilization is fulfilled...
  17. ncbi Inhibition of PMN-elastase activity by semisynthetic glucan sulfates
    Markus Becker
    Pharmaceutical Institute, Christian-Albrechts-University of Kiel, Gutenbergstr. 76, 24118 Kiel, Germany
    Thromb Haemost 89:915-25. 2003
    ..According to enzyme-inhibitor binding studies, SC exhibit structure dependent affinity to the enzyme (K(d) for PMNE: beta-1,3 < alpha-1,4/1,6 < UFH). Finally, SC were shown to inhibit cancer cell-mediated elastinolysis...
  18. ncbi PS3, a semisynthetic beta-1,3-glucan sulfate, diminishes contact hypersensitivity responses through inhibition of L- and P-selectin functions
    Susanne Alban
    Pharmaceutical Institute, Christian Albrechts University, Kiel, Germany
    J Invest Dermatol 129:1192-202. 2009
    ..Again, PS3 had no effect in P-selectin-deficient mice. PS3 is a potent P- and L-selectin inhibitor that may add to the therapy of inflammatory diseases...
  19. ncbi Pharmacokinetic and pharmacodynamic characterization of a medium-molecular-weight heparin in comparison with UFH and LMWH
    Susanne Alban
    Institute of Pharmacy, University of Regensburg, Germany
    Semin Thromb Hemost 28:369-78. 2002
    ..Consequently, substantially lower doses are needed to bring about effects comparable to those of UFH and LMWH...
  20. ncbi Kinetic analysis of heparin and glucan sulfates binding to P-selectin and its impact on the general understanding of selectin inhibition
    Dirk Simonis
    Department of Pharmacy, Rheinische Friedrich Wilhelms University Bonn, An der Immenburg 4, 53121 Bonn, Germany
    Biochemistry 46:6156-64. 2007
    ..Structurally, highly charged compounds with a slow off-rate, such as heparin or glucan sulfates, appear as potent candidates for P-selectin inhibition...
  21. ncbi Perioperative bridging with fondaparinux in a woman with antithrombin deficiency
    Rupert Bauersachs
    Thromb Haemost 97:498-9. 2007
  22. ncbi The influence of various structural parameters of semisynthetic sulfated polysaccharides on the P-selectin inhibitory capacity
    Juliane Fritzsche
    Institute of Pharmaceutical Chemistry, Rheinische Friedrich Wilhelms University Bonn, Germany
    Biochem Pharmacol 72:474-85. 2006
    ..Our study indicates that semisynthetic glucan sulfates with optimal structures block P-selectin excellently and might become promising candidates for anti-inflammatory drugs to replace heparin for certain applications...
  23. ncbi Molecular weight determines the frequency of delayed type hypersensitivity reactions to heparin and synthetic oligosaccharides
    Ralf J Ludwig
    Department of Dermatology, Klinikum der J W Goethe Universitat, Theodor Stern Kai 7, 60590 Frankfurt am Main, Germany
    Thromb Haemost 94:1265-9. 2005
    ..842, p = 0.009). Hence, fondaparinux may be used as a therapeutic alternative in patients with cutaneous DTH relations towards heparin and other polysaccharides...
  24. ncbi Differentiation between the complement modulating effects of an arabinogalactan-protein from Echinacea purpurea and heparin
    Susanne Alban
    Institute of Pharmacy, University of Regensburg, Regensburg, Germany
    Planta Med 68:1118-24. 2002
    ..saline containing EGTA and Mg 2+HPS:human pooled serum RT:room temperature LPS:lipopolysaccharide RaE:rabbit erythrocytes RT:room temperature ShE(A):(sensitised) sheep erythrocytes VB:veronal buffered saline containing Ca 2+ and Mg 2+..
  25. ncbi The ability of different forms of heparins to suppress P-selectin function in vitro correlates to their inhibitory capacity on bloodborne metastasis in vivo
    Ralf J Ludwig
    Department of Dermatology, Johann Wolfgang Goethe-University, Frankfurt am Main, Germany
    Thromb Haemost 95:535-40. 2006
    ..Hence, P-selectin inhibition may constitute a valuable feature to identify anticoagulants that are suitable for anticancer therapy...
  26. ncbi Structural requirements of heparin and related molecules to exert a multitude of anti-inflammatory activities
    Ralf J Ludwig
    Department of Dermatology, Johann Wolfgang Goethe University, Theodor Stern Kai 7, D 60590 Frankfurt am Main, Germany
    Mini Rev Med Chem 6:1009-23. 2006
    ....
  27. ncbi [Statement from the DPhG: DPhG opinion on the proposed health claims regulation]
    Susanne Alban
    Pharm Unserer Zeit 37:424-5. 2008
  28. ncbi Affinity and kinetics of different heparins binding to P- and L-selectin
    Dirk Simonis
    Department of Pharmacy, Rheinische Friedrich Wilhelms University Bonn, Av der Immenburg 4, 531L1 Bonn, Germany
    Semin Thromb Hemost 33:534-9. 2007
    ..These data support recent findings of antimetastatic activities, but illustrate that the intrinsic selectin binding does not entirely reflect the antimetastatic activities in vivo...